Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Zhejiang Yinghuang Pharmaceutical is a Chinese pharmaceutical company specializing in the research, development, and large-scale manufacturing of active pharmaceutical ingredients (APIs) and finished dosage forms. The company's product portfolio primarily addresses therapeutic areas such as cardiovascular health, digestive system disorders, and anti-infective treatments. Key commercial products include generic versions of amlodipine, azithromycin, and omeprazole, which are produced in GMP-certified facilities. Based in Zhejiang province, the company serves both the domestic Chinese market and international pharmaceutical supply chains. Yinghuang is recognized for its capabilities in chemical synthesis and the production of pharmaceutical intermediates.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Ying Huang.